Collection

ACMD drug-specific reports

This series brings together all documents relating to ACMD drug-specific reports.

The Advisory Council carries out in-depth reviews of specific drugs, including their classification under the Misuse of Drugs Act 1971.

Documents

  1. Ketamine: rescheduling and patient group directions

    • Policy paper
  2. Ketamine report

    • Policy paper
  3. Temporary class drug order on benzofury and NBOMe compounds - letter from ACMD

    • Correspondence
  4. ACMD advice on tramadol

    • Research and analysis
  5. ACMD advice on independent prescribing of controlled drugs

    • Guidance
  6. Khat report 2013

    • Research and analysis
  7. ACMD - Recovery from drug and alcohol dependence: an overview of the evidence (2012)

    • Research and analysis
  8. Advisory Council on the Misuse of Drugs (ACMD) Methoxetamine report, 2012

    • Policy paper
  9. Novel psychoactive substances report (2011)

    • Research and analysis
  10. ACMD report on desoxypipradrol

    • Correspondence
  11. Foil report

    • Research and analysis
  12. Advisory Council on the Misuse of Drugs: Consideration of the anabolic steroids

    • Corporate report
  13. Advisory Council on the Misuse of Drugs: Consideration of the anabolic steroids

    • Research and analysis
  14. Advisory Council on the Misuse of Drugs Naphyrone Report (2010)

    • Research and analysis
  15. ACMD report on the consideration of the cathinones

    • Policy paper
  16. ACMD report on the major cannabinoid agonists

    • Independent report
  17. ACMD 1-benzylpiperazine (BZP) Report (2008)

    • Independent report
  18. MDMA ('ecstasy') review

    • Guidance
  19. ACMD report on gamma-butyrolactone (GBL)

    • Guidance
  20. ACMD: Cannabis classification and Public Health (2008)

    • Corporate report
  21. ACMD Drug Facilitated Sexual Assault (DFSA) (2007)

    • Corporate report
  22. Khat Report 2005

    • Corporate report
  23. The Advisory Council’s report - Further consideration of the classification of cannabis under the Misuse of Drugs Act 1971 (2005)

    • Corporate report
  24. ACMD's latest Methylamphetamine Advice

    • Guidance
  25. Advisory Council on the Misuse of Drugs Methylamphetamine review 2005 executive summary

    • Research and analysis
  26. Appendix One: Forensic Science Service – Methylamphetamine

    • Corporate report
  27. The classification of Cannabis under the Misuse of Drugs Act 1971 (2002)

    • Policy paper
Published 4 June 2013